Jonathan Peter Evans

Jonathan Peter Evans

Auto-generated profile, based on publicly available information

Jonathan Peter Evans

Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK; University of Exeter, Exeter, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Patient Related Outcome Measures
Verified
Journal Article
Open access
PDF file
JEJonathan P Evans
Jonathan P Evans
ASAlexander Smith
Alexander Smith
CGChris Gibbons
Chris Gibbons
JAJordi Alonso
Jordi Alonso
JVJose M. Valderas
Jose M. Valderas
The interest in patient-reported outcome measures (PROMs) continues to increase as recognition of their potential utility rises in an effort to make health systems more patient-centered. The US National Institutes of Health (NIH) Patient-Reported Outcomes Measurement Information System® (PROMIS®) has used state of the art psychometric and statistical techniques to create a universal PROMs language, with potential application across the whole spectrum of health conditions, languages, and geographic locations. PROMIS offers a versatile platform where specific health domains are assessed using both standardized short forms and computerized adaptive tests, which are automatically tailored to individual patients. The scores of each health domain or a standardized profile of multiple domains are all scored on a common metric scale. PROMIS is increasingly recognized as the international gold standard for patient-centered assessment, although the use of these tools in the UK is limited. In this review, the developmental methodology of the PROMIS is described with discussion of its relevant strengths and limitations for use in the UK. We provide a case study of the largest application of the PROMIS tools in the UK as an example of straightforward integration into health-care research. Barriers to the uptake of PROMIS in the UK include the technology requirement, measurement tradition, and lack of a clear understanding of its benefits, and although potential stakeholders should cautiously consider its use, its impressive potential and increasing international utilization should be recognized.

10 June 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
HGHarry D Green
Harry D Green
AJAlistair Jones
Alistair Jones
JEJonathan P Evans
Jonathan P Evans
AWAndrew R Wood
Andrew R Wood
RBRobin N Beaumont
Robin N Beaumont
MWMichael N Weedon
Michael N Weedon
Frozen shoulder is a painful condition that often requires surgery and affects up to 5% of individuals aged 40–60 years. Little is known about the causes of the condition, but diabetes is a strong risk factor. To begin to understand the biological mechanisms involved, we aimed to identify genetic variants associated with frozen shoulder and to use Mendelian randomization to test the causal role of diabetes. We performed a genome-wide association study (GWAS) of frozen shoulder in the UK Biobank using data from 10,104 cases identified from inpatient, surgical and primary care codes. We used data from FinnGen for replication and meta-analysis. We used one-sample and two-sample Mendelian randomization approaches to test for a causal association of diabetes with frozen shoulder. We identified five genome-wide significant loci. The most significant locus (lead SNP rs28971325; OR = 1.20, [95% CI: 1.16–1.24], p = 5x10-29) contained WNT7B. This variant was also associated with Dupuytren’s disease (OR = 2.31 [2.24, 2.39], p<1x10-300) as were a further two of the frozen shoulder associated variants. The Mendelian randomization results provided evidence that type 1 diabetes is a causal risk factor for frozen shoulder (OR = 1.03 [1.02–1.05], p = 3x10-6). There was no evidence that obesity was causally associated with frozen shoulder, suggesting that diabetes influences risk of the condition through glycemic rather than mechanical effects. We have identified genetic loci associated with frozen shoulder. There is a large overlap with Dupuytren’s disease associated loci. Diabetes is a likely causal risk factor. Our results provide evidence of biological mechanisms involved in this common painful condition.

1 August 2018 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
SGSian Gallacher
Sian Gallacher
JBJames C. Beazley
James C. Beazley
JEJon Evans
Jon Evans
RARahul Anaspure
Rahul Anaspure
DSDavid Silver
David Silver
CSChris Smith
Chris Smith

1 April 2018 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
JEJonathan P. Evans
Jonathan P. Evans
CSChris D. Smith
Chris D. Smith
NFNicola F. Fine
Nicola F. Fine
IPIan Porter
Ian Porter
JGJaheeda Gangannagaripalli
Jaheeda Gangannagaripalli
JVJose M. Valderas
Jose M. Valderas

25 February 2020 in Shoulder & Elbow
Verified
Journal Article
Closed access
PDF file
PPPhoebe Parker
Phoebe Parker
NFNicholas D Furness
Nicholas D Furness
JEJonathan P Evans
Jonathan P Evans
TBTimothy Batten
Timothy Batten
WWWilliam J White
William J White
CSChristopher D Smith
Christopher D Smith
Background: Total elbow arthroplasty is a low volume procedure. We aimed to evaluate complication rates and cumulative percentages associated with the most frequently used contemporary implants and for the commonest indications. Methods: A systematic literature search of all studies reporting complications following total elbow arthroplasty with 12-month minimum follow-up was undertaken. Quality of studies was assessed with the Methodological-Index-for-Non-Randomised-studies criteria. British NJR data identified the most common UK prostheses and indications. The complication rates for all undesirable events contributing to patient outcome were extracted and cumulative percentages were calculated. Results: One hundred seventeen studies were screened, 12 studies included, totalling 815 procedures. Mean follow-up was 3.8 years. The overall complication cumulative percentage was 60.7%, significantly higher than that seen in other joint arthroplasty, including a 6.5% deep infection rate. Nerve injury was comparable between implants at around 4.1%. Radiographic loosening had a cumulative rate of 17.2%. Revision for symptomatic aseptic loosening was 6.3%. Conclusions: This is the largest systematic review of the complications of total elbow arthroplasty. Surgeons should be aware of differing complications related to their implant of choice, each having its own specific complication. Trauma as an indication appears to have an increased complication rates compared to inflammatory arthropathy. There is a lack of literature regarding the independent results of osteoarthritis as a specific indication for total elbow arthroplasty.

8 February 2022 in British Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
MBMarcus Bateman
Marcus Bateman
JEJonathan P Evans
Jonathan P Evans
VVViana Vuvan
Viana Vuvan
VJVal Jones
Val Jones
AWAdam C Watts
Adam C Watts
BVBill Vicenzino
Bill Vicenzino
Objectives To develop a core outcome set for lateral elbow tendinopathy (COS-LET) and to provide guidance for outcome evaluation in future studies. Methods We implemented a multi-stage mixed-methods design combining two systematic reviews, domain mapping of outcome measurement instruments to the core domains of tendinopathy, psychometric analysis of instruments, two patient focus groups and a Delphi study incorporating two surveys and an international consensus meeting. Following the OMERACT guidelines, we used a 70% threshold for consensus. Results 38 clinicians/researchers and 9 patients participated. 60 instruments were assessed for inclusion. The only instrument that was recommended for the COS-LET was Patient Rated Tennis Elbow Evaluation (PRTEE) for the disability domain. Interim recommendations were made to use: the PRTEE function subscale for the function domain; PRTEE pain subscale items 1, 4 and 5 for the pain over a specified time domain; pain-free grip strength for the physical function capacity domain; a Numerical Rating Scale measuring pain on gripping for the pain on activity/loading domain; and time off work for the participation in life activities domain. No recommendations could be made for the quality-of-life, patient rating of condition and psychological factors domains. Conclusions The COS-LET comprises the PRTEE for the disability domain. Interim-use recommendations included PRTEE subscales, time off work, pain-free grip strength and a Numerical Rating Scale measuring pain on gripping. Further work is required to validate these interim measures and develop suitable measures to capture the other domains.